Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Short Report
  • Published:

Homologous recombination induced by replication inhibition, is stimulated by expression of mutant p53

Abstract

Cell cycle control, faithful DNA replication, repair and recombination are associated in a network of pathways controlling genome maintenance. In mammalian cells, inhibition of replication produces DNA breaks and induces RAD51-dependent recombination, in a late step. Here we examine whether the status of p53 affects this process in mouse L-cells containing a recombination substrate. We show that expression of the mutant His175p53 strongly stimulates recombination induced by aphidicolin, in a late step (kinetically related to the RAD51 step). Mutant p53 stimulates recombination induced by the replication elongation inhibitors (aphidicolin, hydroxyurea and Ara-C) but is without effect on recombination induced by the initiation inhibitors (mimosine and ciclopirox olamine). We compared the impact of several p53 mutations showing different effects on the G1 checkpoint and on recombination. We show that the mutant Pro273p53 protein, which does not alter the G1 checkpoint, strongly stimulates recombination induced by elongation inhibitors. These results show that p53 can act on recombination induced by replication arrest independently of its role in the G1 checkpoint. An action of p53 via the RAD51 pathway is discussed.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  • Baumann P, Benson FE, West SC . 1996 Cell 87: 757–766

  • Baumann P, West SC . 1998 Trends Biochem. Sci. 23: 247–251

  • Bertrand P, Rouillard D, Boulet A, Levalois C, Soussi T, Lopez BS . 1997 Oncogene 14: 1117–1122

  • Bouffler SD, Kemp CJ, Balmain A, Cox R . 1995 Cancer Res. 55: 3883–3889

  • Buchhop S, Gibson MK, Wang XW, Wagner P, Sturzbecher HW, Harris CC . 1997 Nucleic Acids Res. 25: 3868–3874

  • Cavenee WK, Dryja TP, Phillips RA, Benedict WF, Godbout R, Gallie BL, Murphree AL, Strong LC, White RL . 1983 Nature 305: 779–784

  • Deng C, Zhang P, Harper JW, Elledge SJ, Leder P . 1995 Cell 82: 675–684

  • Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery Jr CA, Butel JS, Bradley A . 1992 Nature 356: 215–221

  • Dudenhoffer C, Kurth M, Janus F, Deppert W, Wiesmuller L . 1999 Oncogene 18: 5773–5784

  • Gottifredi V, Shieh S, Taya Y, Prives C . 2001 Proc. Natl. Acad. Sci. USA 98: 1036–1041

  • Hartwell L . 1992 Cell 71: 543–546

  • Hartwell LH, Kastan MB . 1994 Science 266: 1821–1828

  • Hollstein M, Sidransky D, Vogelstein B, Harris CC . 1991 Science 253: 49–53

  • Hyrien O . 2000 Biochimie. 82: 5–17

  • Jimenez GS, Nister M, Stommel JM, Beeche M, Barcase EA, Zhang X-Q, O'Gorman S, Wahl GM . 2000 Nature Genet. 26: 37–43

  • Lambert S, Lopez BS . 2000 EMBO J. 19: 3090–3099

  • Levenson V, Hamlin JL . 1993 Nucleic Acids Res. 21: 3997–4004

  • Levine AJ, Momand J, Finlay CA . 1991 Nature 351: 453–456

  • Liskay RM, Stachelek JL, Letsou A . 1984 Cold Spring Harb. Symp. Quant. Biol. 49: 183–189

  • Maacke H, Jost K, Opitz S, Miska S, Yuan Y, Hasselbach L, Luttges J, Kalthoff H, Sturzbecher HW . 2000 Oncogene 19: 2791–2795

  • Marmorstein LY, Ouchi T, Aaronson SA . 1998 Proc. Natl. Acad. Sci. USA 95: 13869–13874

  • Mekeel KL, Tang W, Kachnic LA, Luo CM, DeFrank JS, Powell SN . 1997 Oncogene 14: 1847–1857

  • Mizuta R, LaSalle JM, Cheng HL, Shinohara A, Ogawa H, Copeland N, Jenkins NA, Lalande M, Alt FW . 1997 Proc. Natl. Acad. Sci. USA 94: 6927–6932

  • Onno M, Nakamura T, Hillova J, Hill M . 1992 Oncogene 7: 2519–2523

  • Purandare SM, Patel PI . 1997 Genome Res. 7: 773–786

  • Rothstein R, Michel B, Gangloff S . 2000 Genes Dev. 14: 1–10

  • Saintigny Y, Delacote F, Vares G, Petitot F, Lambert S, Averbeck D, Lopez BS . 2001 EMBO J. 20: 3861–3870

  • Saintigny Y, Rouillard D, Chaput B, Soussi T, Lopez BS . 1999 Oncogene 18: 3553–3563

  • Scully R, Chen J, Plug A, Xiao Y, Weaver D, Feunteun J, Ashley T, Livingston DM . 1997 Cell 88: 265–275

  • Sturzbecher HW, Donzelmann B, Henning W, Knippschild U, Buchhop S . 1996 EMBO J. 15: 1992–2002

  • Susse S, Janz C, Janus F, Deppert W, Wiesmuller L . 2000 Oncogene 19: 4500–4512

  • Wiesmuller L, Cammenga J, Deppert WW . 1996 J. Virol. 70: 737–744

  • Willers H, McCarthy EE, Wu B, Wunsch H, Tang W, Taghian DG, Xia F, Powell SN . 2000 Oncogene 19: 632–639

Download references

Acknowledgements

We thank D Rouillard (Institut Curie, Paris) for FACS expertise. We are grateful to Drs P Bertrand, D Marsh, R Monnat for critical reading of the manuscript. Thanks are due to M Liskay for providing the pJS3-10 cell lines. Y Saintigny was supported by a fellowship from ‘la Foundation pour la Recherche Médicale’. This work was supported by Electricité de France, ARC (9822 and 9238).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Bernard S Lopez.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Saintigny, Y., Lopez, B. Homologous recombination induced by replication inhibition, is stimulated by expression of mutant p53. Oncogene 21, 488–492 (2002). https://doi.org/10.1038/sj.onc.1205040

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1205040

Keywords

This article is cited by

Search

Quick links